West Africa: Strengthening Lassa Fever Vaccine Research and Trial Capacity in West Africa
In West Africa, Lassa fever remains a persistent and recurring health threat, causing hundreds of lives each year and underscoring urgent need for sustained investment in research and vaccine manufacturing capacity. In the first five months of 2025 alone, Nigeria reported over 717 confirmed cases and 138 deaths, highlighting the escalating risk and the critical…
